Clinical Trial Update: S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating lapatinib in patients with locally advanced or metastatic stomach cancer, including va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Adenocarcinoma of the Stomach
• Gastric Cancer
• Intestinal Adenocarcinoma of the Stomach
• Mixed Adenocarcinoma of the Stomach

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach | Phase 2 | Status: COMPLETED